Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Motoi Kanagawa

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
International Journal of Molecular Sciences|December 10, 2021
Dystroglycanopathy: From Elucidation of Molecular and Pathological Mechanisms to Development of Treatment MethodsMotoi Kanagawa
Journal of Neuromuscular Diseases|March 12, 2019
Myo-Glyco disease Biology: Genetic Myopathies Caused by Abnormal Glycan Synthesis and DegradationMotoi Kanagawa
Journal of Neuromuscular Diseases|October 31, 2017
Muscular Dystrophy with Ribitol-Phosphate Deficiency: A Novel Post-Translational Mechanism in DystroglycanopathyMotoi Kanagawa, Tatsushi Toda
Journal of Human Genetics|September 14, 2006
The genetic and molecular basis of muscular dystrophy: roles of cell-matrix linkage in the pathogenesisMotoi Kanagawa, Tatsushi Toda
Journal of Biochemistry|February 3, 2018
Ribitol-phosphate-a newly identified posttranslational glycosylation unit in mammals: structure, modification enzymes and relationship to human diseasesMotoi Kanagawa, Tatsushi Toda
Brain and Nerve = Shinkei Kenkyu No Shinpo|November 10, 2011
[Recent Advances in α-dystroglycanopathy]Atsushi Kuga, Motoi Kanagawa, Tatsushi Toda
Cell Regeneration (London, England)|July 5, 2026
Systemic regeneration medicines for muscular dystrophy: progress and challenges in pro-regenerative drug developmentSo-Ichiro Fukada, Atsushi Kubo, Motoi Kanagawa, et al.
The Journal of Biological Chemistry|January 26, 2012
Mislocalization of fukutin protein by disease-causing missense mutations can be rescued with treatments directed at folding ameliorationMasaji Tachikawa, Motoi Kanagawa, Chih-Chieh Yu, et al.
Plos One|September 9, 2014
Contribution of dysferlin deficiency to skeletal muscle pathology in asymptomatic and severe dystroglycanopathy models: generation of a new model for Fukuyama congenital muscular dystrophyMotoi Kanagawa, Zhongpeng Lu, Chiyomi Ito, et al.
Journal of Biochemistry|December 23, 2023
Endogenous reductase activities for the generation of ribitol-phosphate, a CDP-ribitol precursor, in mammalsShunsuke Hoshino, Hiroshi Manya, Rieko Imae, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
International Journal of Molecular Sciences|December 10, 2021
Dystroglycanopathy: From Elucidation of Molecular and Pathological Mechanisms to Development of Treatment MethodsMotoi Kanagawa
Journal of Neuromuscular Diseases|March 12, 2019
Myo-Glyco disease Biology: Genetic Myopathies Caused by Abnormal Glycan Synthesis and DegradationMotoi Kanagawa
Journal of Neuromuscular Diseases|October 31, 2017
Muscular Dystrophy with Ribitol-Phosphate Deficiency: A Novel Post-Translational Mechanism in DystroglycanopathyMotoi Kanagawa, Tatsushi Toda
Journal of Human Genetics|September 14, 2006
The genetic and molecular basis of muscular dystrophy: roles of cell-matrix linkage in the pathogenesisMotoi Kanagawa, Tatsushi Toda
Journal of Biochemistry|February 3, 2018
Ribitol-phosphate-a newly identified posttranslational glycosylation unit in mammals: structure, modification enzymes and relationship to human diseasesMotoi Kanagawa, Tatsushi Toda
Brain and Nerve = Shinkei Kenkyu No Shinpo|November 10, 2011
[Recent Advances in α-dystroglycanopathy]Atsushi Kuga, Motoi Kanagawa, Tatsushi Toda
Cell Regeneration (London, England)|July 5, 2026
Systemic regeneration medicines for muscular dystrophy: progress and challenges in pro-regenerative drug developmentSo-Ichiro Fukada, Atsushi Kubo, Motoi Kanagawa, et al.
The Journal of Biological Chemistry|January 26, 2012
Mislocalization of fukutin protein by disease-causing missense mutations can be rescued with treatments directed at folding ameliorationMasaji Tachikawa, Motoi Kanagawa, Chih-Chieh Yu, et al.
Plos One|September 9, 2014
Contribution of dysferlin deficiency to skeletal muscle pathology in asymptomatic and severe dystroglycanopathy models: generation of a new model for Fukuyama congenital muscular dystrophyMotoi Kanagawa, Zhongpeng Lu, Chiyomi Ito, et al.
Journal of Biochemistry|December 23, 2023
Endogenous reductase activities for the generation of ribitol-phosphate, a CDP-ribitol precursor, in mammalsShunsuke Hoshino, Hiroshi Manya, Rieko Imae, et al.
Pageof 7